Kansanterveyslaitos KTL

A selective broth enrichment combined with real-time nuc-mecA-PCR in the exlusion of MRSA

Pasanen T; Korkeila M; Mero S; Tarkka E; Piiparinen H; Vuopio Varkila J; Vaara M; Tissari P
APMIS : 1 (2010)

Avohoidon potilaista eristettyjen bakteerien lääkeresistenssi Suomessa 1997-2000

Huovinen P; Kaukoranta H; Katila M-L; Nissinen A; Vaara M; FiRe-verkosto
Suom Lääkäril (2002)

Bakteerien antibioottiresistenssi; 2000-luvun maailmanlaajuinen uhka

Vaara M
Suom Lääkäril (1997)

Bakteerilääkkeiden lähteet eivät ole ehtymässä

Vaara M
Duodecim (1998)

Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia

Suppola JP; Kuikka A; Vaara M; Valtonen VV
Scand J Infect Dis (1998)

Costs of an outbreak of meticillin-resistant Staphylococcus aureus

Kanerva M; Blom M; Tuominen U; Kolho E; Anttila VJ; Vaara M; Virolainen-Julkunen A; Lyytikäinen O
J Hosp Infect (2007)

Detection of virulence genes of Clostridium difficile by multiplex PCR

Antikainen J; Pasanen T; Mero S; Tarkka E; Kirveskari J; Kotila S; Mentula S; Könönen E; Virolainen-Julkunen AR; Vaara M; Tissari P
APMIS : 8 (2009)

Distribution of streptococcal inhibitor of compelement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 Group A

Hoe NP; Vuopio-Varkila J; Vaara M; Grigsby D; De Lorenzo D; FU, Y-X; Dou, S-J; Pan X; Nakashima K; Musser JM
J Infect Dis (2001)

Effects of a 6-month exercise program on patients with multiple sclerosis : a randomized study

Romberg A; Virtanen A; Ruutiainen J; Aunola S; Karppi SL; Vaara M; Surakka J; Pohjolainen T; Seppänen A
Neurology : 11 (2004)

Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods

Vuori-Holopainen E; Salo E; Saxén H; Hedman K; Hyypiä T; Lahdenperä R; Leinonen M; Tarkka E; Vaara M; Peltola H
Clin Infect Dis : 5 (2002)

Evaluation of a commercial MRSA assay when multiple MRSA strains are causing epidemics

Sissonen S; Pasanen T; Salmenlinna S; Vuopio-Varkila J; Tarkka E; Vaara M; Tissari P
Eur J Clin Microbiol Infect Dis (2009)

First isolation of Clostridium difficile PCR ribotype 027 in Finland

Lyytikäinen O; Mentula S; Könönen E; Kotila S; Tarkka E; Anttila V; Mattila E; Kanerva M; Vaara M; Valtonen V
EuroSurveillance : E071108 (2007)

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009

Österblad M; Kirveskari J; Koskela S; Tissari P; Vuorenoja K; Hakanen AJ; Vaara M; Jalava J
EuroSurveillance : 40 (2009)

Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period

Lyytikäinen O; Vaara M; Järviluoma E; Rosenqvist K; Tiittanen L; Valtonen V
Eur J Clin Microbiol Infect Dis (1996)

Keuhkokuumeen hoito (Käypä hoito -suositus)

Honkanen P; Jartti A; Järvinen A; Korppi M; Patja K; Puolijoki H; Ruuskanen O; Syrjälä H; Timonen O; Vaara M
Duodecim : 17 (2008)

Kliinisen mikrobiologian laboratoriot Suomessa 1999

Vaara M
Moodi : 6 (1999)

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

Salminen MK; Tynkkynen S; Rautelin H; Saxelin M; Vaara M; Ruutu P; Sarna S; Valtonen V; Järvinen A
Clin Infect Dis : 35 (2002)

Lipopolysaccharides of polymyxin B-resistant mutants Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A

Nummila K; Kilepäinen I; Zähringer U; Vaara M; Helander IH
Mol Microbiol (1995)

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients

Ibrahem S; Salmenlinna S; Lyytikäinen O; Vaara M; Vuopio-Varkila J
Microbiology and Infectious Diseases : 11 (2008)

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients

Ibrahem S; Salmenlinna S; Lyytikäinen O; Vaara M; Vuopio-Varkila J
Clinical microbiology and infection (2008)

"Vaara M" - Selaus tekijän mukaan Kansanterveyslaitos KTL

A selective broth enrichment combined with real-time nuc-mecA-PCR in the exlusion of MRSA ﻿

Avohoidon potilaista eristettyjen bakteerien lääkeresistenssi Suomessa 1997-2000 ﻿

Bakteerien antibioottiresistenssi; 2000-luvun maailmanlaajuinen uhka ﻿

Bakteerilääkkeiden lähteet eivät ole ehtymässä ﻿

Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia ﻿

Costs of an outbreak of meticillin-resistant Staphylococcus aureus ﻿

Detection of virulence genes of Clostridium difficile by multiplex PCR ﻿

Distribution of streptococcal inhibitor of compelement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 Group A ﻿

Effects of a 6-month exercise program on patients with multiple sclerosis : a randomized study ﻿

Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods ﻿

Evaluation of a commercial MRSA assay when multiple MRSA strains are causing epidemics ﻿

First isolation of Clostridium difficile PCR ribotype 027 in Finland ﻿

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009 ﻿

Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period ﻿

Keuhkokuumeen hoito (Käypä hoito -suositus) ﻿

Kliinisen mikrobiologian laboratoriot Suomessa 1999 ﻿

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland ﻿

Lipopolysaccharides of polymyxin B-resistant mutants Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A ﻿

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients ﻿

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients ﻿

A selective broth enrichment combined with real-time nuc-mecA-PCR in the exlusion of MRSA

Avohoidon potilaista eristettyjen bakteerien lääkeresistenssi Suomessa 1997-2000

Bakteerien antibioottiresistenssi; 2000-luvun maailmanlaajuinen uhka

Bakteerilääkkeiden lähteet eivät ole ehtymässä

Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia

Costs of an outbreak of meticillin-resistant Staphylococcus aureus

Detection of virulence genes of Clostridium difficile by multiplex PCR

Distribution of streptococcal inhibitor of compelement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 Group A

Effects of a 6-month exercise program on patients with multiple sclerosis : a randomized study

Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods

Evaluation of a commercial MRSA assay when multiple MRSA strains are causing epidemics

First isolation of Clostridium difficile PCR ribotype 027 in Finland

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009

Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period

Keuhkokuumeen hoito (Käypä hoito -suositus)

Kliinisen mikrobiologian laboratoriot Suomessa 1999

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

Lipopolysaccharides of polymyxin B-resistant mutants Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients

Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients